This is particularly evident in digestive system cancers, where TGFβ affects the tumor microenvironment by promoting epithelial-to-mesenchymal transition (EMT), enhancing cell motility, and modulating the immune response to provide an environment conducive to cancer progression [9]. Here, TGFB1 is linked to cancer.